MedVi vs Embody: Cost, meds, shipping and support compared
MedVi vs Embody quickly: Embody is the lower-cost, fast-delivery option, while MedVi emphasizes a clinical compounded semaglutide program with 24/7 certified medical support. Early verdict: choose Embody if your top priority is the lowest monthly price and rapid shipping; choose MedVi if you want a promoted introductory rate plus round-the-clock clinician access and a no-clinic, clinically dosed compounded program.
Key differences at a glance: price, medication options, shipping, support
This comparison uses only supplied facts for MedVi and Embody and highlights the most distinctive differences: pricing structure and promotions, availability of tirzepatide, shipping speed and delivery claims, and clinical support plus program features. Each section compares the two platforms directly.
1. Pricing and promotions
MedVi promotes a winter first-month price of $179 including fast, free shipping, but its ongoing standalone month price is $299 and a three-month plan is $649 (about $216/month). Embody advertises a $69/month semaglutide price (reduced from $299) and $119/month tirzepatide, with a flat locked-in monthly pricing model and no long-term commitment. In short, Embody advertises a much lower ongoing price; MedVi advertises a promotional entry point that increases for subsequent months.
2. Medication options – semaglutide versus tirzepatide
Both providers use compounded GLP-1 medications. MedVi offers clinically dosed compounded semaglutide only, explicitly noting it is semaglutide-only and does not provide branded options like Ozempic or Wegovy as part of its core offering. Embody offers compounded semaglutide at $69/month and also offers compounded tirzepatide at $119/month. If access to tirzepatide is important, Embody provides that option while MedVi does not.
3. Shipping speed and logistics
MedVi states fast, free shipping is included with its promotional $179 first month. Embody promises free shipping with delivery in 1-2 days after clinician approval, which the source highlights as one of the faster delivery commitments in the space. Both platforms fill medication at licensed pharmacies; Embody emphasizes a specific 1-2 day arrival window after approval.
4. Clinical process and support
MedVi emphasizes a simple online intake with no clinic visits and 24/7 support from certified medical professionals, plus clinician review through an affiliated network. Embody also handles licensed provider review online and advertises doctor-prescribed treatment with regular check-ins, and 24/7 support access for dosing and side-effect questions. MedVi highlights clinically dosed compounded semaglutide and 24/7 certified support as core features; Embody highlights telemed visits included and ongoing check-ins while positioning itself as a lean, prescription-forward model.
5. Regulatory note and medication status
Both sources state that their compounded medications are not FDA-approved finished products. MedVi notes compounded medications are produced in FDA-regulated facilities but are not FDA-approved or evaluated for safety, effectiveness or quality. Embody includes the same regulatory note that compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality. Both providers advise clinician discretion and that prescriptions are subject to provider review.
Comparison table
| Criteria | MedVi | Embody |
|---|---|---|
| Starting price | $179 first month (promo); $299 standalone month | $69/month semaglutide (was $299); $119/month tirzepatide |
| Medications offered | Compounded semaglutide only | Compounded semaglutide and compounded tirzepatide |
| Shipping | Fast, free shipping included with promo | Free shipping; ships in 1-2 days after approval |
| Clinic visits | No clinic visits required; online intake and clinician review | No clinic visits required; telemed review included |
| Support | 24/7 support from certified medical professionals | 24/7 support access; regular check-ins mentioned |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-approved |
Pros and cons summarized
MedVi pros include a clinically dosed compounded semaglutide program, a simple online process with no clinic visits, and 24/7 certified medical support. MedVi cons include a sharp price increase after the first promotional month and no tirzepatide option. Embody pros include the lowest entry price for semaglutide at $69/month, an available tirzepatide option at $119/month, fast 1-2 day shipping, and no long-term commitment. Embody cons include fewer premium features and the note that the $69 pricing is a limited-time offer that may increase.
How to choose: final guidance for MedVi vs Embody
Choose Embody if your priority is the lowest reported monthly price for compounded semaglutide, access to compounded tirzepatide, and very fast 1-2 day shipping after approval. Choose MedVi if you value a promoted first-month price plus ongoing 24/7 certified medical support, a simple online intake with no clinic visits, and a clinically dosed compounded semaglutide program. Both providers use compounded GLP-1 medications that are not FDA-approved finished products and require clinician review before prescriptions are issued.
Primary keyword used: MedVi vs Embody